Prevalence of co‐existent <scp>COVID</scp>‐19‐associated pulmonary aspergillosis (<scp>CAPA</scp>) and its impact on early mortality in patients with <scp>COVID</scp>‐19‐associated pulmonary mucormycosis (<scp>CAPM</scp>)

20245 citationsJournal Article

Authors

Valliappan Muthu · Post Graduate Institute of Medical Education and Research

Ritesh Agarwal · Post Graduate Institute of Medical Education and Research

Shivaprakash M. Rudramurthy · Post Graduate Institute of Medical Education and Research

Deepak Thangaraju · Kovai Medical Center and Hospital

Manoj Shevkani · Apollo Hospitals

Atul Patel · Sterling Hospitals

Prakash Shastri

Abstract

Coinfection of CAPA and CAPM was not uncommon in our CAPM patients and portends a worse prognosis. Prospective studies from different countries are required to know the impact of mixed mould infection.

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Pneumocystis jirovecii pneumonia detection and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Mycoses

Volume 67, Issue 5, pp. e13745-e13745

DOI: 10.1111/myc.13745

Field-Weighted Citation Impact: 2.05